Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Agenus Inc (AGEN)

$3.91 0.16 (3.93%)

17:22 EST AGEN Stock Quote Delayed 15 Minutes

Volume:

Previous Close $3.91

Market Cap 406.64M

PE Ratio -2.47

EPS -1.58

Volume (Avg. Vol.) 992,300

Day's Range 3.90 - 4.10

52-Week Range 1.95 - 4.57

Dividend & Yield N/A (N/A)

AGEN Stock Predictions, Articles, and Agenus Inc News

From InvestorPlace
From the Web

4 Market-Beating Sector ETFs and Stocks

By Zacks Investment Research Feb 28, 2018

A few sectors have easily survived the market rout and are crushing the broad market this month. Compare Brokers...

Agenus (AGEN) Up 24.5% Since Last Earnings Report: Can It Continue?

From Zacks Investment Research Dec 4, 2019

Agenus (AGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

What Type Of Shareholder Owns Agenus Inc.’s (NASDAQ:AGEN)?

From Simply Wall St Nov 29, 2019

Every investor in Agenus Inc. (NASDAQ:AGEN) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it’s not unusual to see insiders<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agen/agenus/news/what-type-of-shareholder-owns-agenus-inc-s-nasdaqagen/">Read More...</a></div>

Commit To Buy Agenus At $4, Earn 39.2% Annualized Using Options

From Market News Video Nov 20, 2019

Investors eyeing a purchase of Agenus Inc (AGEN) shares, but cautious about paying the going market price of $4.37/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2020 put at the $4 strike, which has a bid at the time of this writing of 40 cents..

Is the Options Market Predicting a Spike in Agenus (AGEN) Stock?

From Zacks Investment Research Nov 20, 2019

Investors need to pay close attention to Agenus (AGEN) stock based on the movements in the options market lately.

The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data

From Benzinga Nov 20, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 19) 89bio Inc (NASDAQ: ETNB...

Stocks That Hit 52-Week Highs On Tuesday

From Benzinga Nov 19, 2019

During Tuesday's morning session, 117 companies made new 52-week highs. Interesting Highlights: The largest company on a market cap basis to set a new 52-week high was Apple...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

A

Strong Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!